CBD

U.S. CBD Sales To Grow An Average Of 107% Annually Through 2023

Cannabidiol best known for its perceived medical benefits

It’s no secret by now that the marijuana industry is a big-money business. Having grown from $3.4 billion in legal global sales in 2014 to hit nearly $11 billion worldwide in 2018, it demonstrates just how quickly “going green” is catching on with consumers and investors.

However, there’s a potentially larger growth trend contained within the cannabis movement that investors simply have to know about: Cannabidiol (CBD).

CBD growth could be off the charts

Cannabidiol is the nonpsychoactive cannabinoid that’s best known for its perceived medical benefits. Since products infused with CBD don’t get the user high, it has substantially broader appeal than products containing tetrahydrocannabinol (THC), the cannabinoid that gives consumers a buzz.

Further, CBD can be extracted from both the cannabis and hemp plant, whereas THC derives almost entirely from the cannabis plant, since hemp often contains very low levels of THC. Hemp plants are considerably cheaper to grow than cannabis, making hemp the preferred crop choice for CBD extraction.


To Read The Rest Of This Article On Motley Fool, Click Here

Click to comment

Leave a Reply

Your email address will not be published.

CHAMPS Smoke Shop Report, or ‘CSS’, online source for the updates and innovations on the smoke shop scene. News and information are geared strictly to accessories retail channels, with distribution limited to retailers that Smoke Shop products and wholesalers.

Newsletter

Stay informed with the most up-to-date industry news to help you grow your business: subscribe to our newsletter below!


To Top